These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1159 related items for PubMed ID: 16952631

  • 1. Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder.
    Karakiewicz PI, Shariat SF, Palapattu GS, Gilad AE, Lotan Y, Rogers CG, Vazina A, Gupta A, Bastian PJ, Perrotte P, Sagalowsky AI, Schoenberg M, Lerner SP.
    J Urol; 2006 Oct; 176(4 Pt 1):1354-61; discussion 1361-2. PubMed ID: 16952631
    [Abstract] [Full Text] [Related]

  • 2. Nomograms provide improved accuracy for predicting survival after radical cystectomy.
    Shariat SF, Karakiewicz PI, Palapattu GS, Amiel GE, Lotan Y, Rogers CG, Vazina A, Bastian PJ, Gupta A, Sagalowsky AI, Schoenberg M, Lerner SP.
    Clin Cancer Res; 2006 Nov 15; 12(22):6663-76. PubMed ID: 17121885
    [Abstract] [Full Text] [Related]

  • 3. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
    Shariat SF, Karakiewicz PI, Palapattu GS, Lotan Y, Rogers CG, Amiel GE, Vazina A, Gupta A, Bastian PJ, Sagalowsky AI, Schoenberg MP, Lerner SP.
    J Urol; 2006 Dec 15; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
    [Abstract] [Full Text] [Related]

  • 4. Precystectomy nomogram for prediction of advanced bladder cancer stage.
    Karakiewicz PI, Shariat SF, Palapattu GS, Perrotte P, Lotan Y, Rogers CG, Amiel GE, Vazina A, Gupta A, Bastian PJ, Sagalowsky AI, Schoenberg M, Lerner SP.
    Eur Urol; 2006 Dec 15; 50(6):1254-60; discussion 1261-2. PubMed ID: 16831511
    [Abstract] [Full Text] [Related]

  • 5. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
    Yu RJ, Stein JP, Cai J, Miranda G, Groshen S, Skinner DG.
    J Urol; 2006 Aug 15; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
    [Abstract] [Full Text] [Related]

  • 6. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
    Dotan ZA, Kavanagh K, Yossepowitch O, Kaag M, Olgac S, Donat M, Herr HW.
    J Urol; 2007 Dec 15; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
    [Abstract] [Full Text] [Related]

  • 7. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
    Boudreaux KJ, Clark PE, Lowrance WT, Rumohr JA, Barocas DA, Cookson MS, Smith JA, Chang SS.
    J Urol; 2009 Feb 15; 181(2):540-5; discussion 546. PubMed ID: 19084855
    [Abstract] [Full Text] [Related]

  • 8. Residual pathological stage at radical cystectomy significantly impacts outcomes for initial T2N0 bladder cancer.
    Isbarn H, Karakiewicz PI, Shariat SF, Capitanio U, Palapattu GS, Sagalowsky AI, Lotan Y, Schoenberg MP, Amiel GE, Lerner SP, Sonpavde G.
    J Urol; 2009 Aug 15; 182(2):459-65; discussion 465. PubMed ID: 19524971
    [Abstract] [Full Text] [Related]

  • 9. Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy.
    Quek ML, Stein JP, Nichols PW, Cai J, Miranda G, Groshen S, Daneshmand S, Skinner EC, Skinner DG.
    J Urol; 2005 Jul 15; 174(1):103-6. PubMed ID: 15947587
    [Abstract] [Full Text] [Related]

  • 10. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
    Steven K, Poulsen AL.
    J Urol; 2007 Oct 15; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
    [Abstract] [Full Text] [Related]

  • 11. Prognostic significance of vascular invasion in patients with bladder cancer who underwent radical cystectomy.
    Harada K, Sakai I, Hara I, Eto H, Miyake H.
    Int J Urol; 2005 Mar 15; 12(3):250-5. PubMed ID: 15828951
    [Abstract] [Full Text] [Related]

  • 12. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
    Sanderson KM, Cai J, Miranda G, Skinner DG, Stein JP.
    J Urol; 2007 Jun 15; 177(6):2088-94. PubMed ID: 17509294
    [Abstract] [Full Text] [Related]

  • 13. Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder.
    Rogers CG, Palapattu GS, Shariat SF, Karakiewicz PI, Bastian PJ, Lotan Y, Gupta A, Vazina A, Gilad A, Sagalowsky AI, Lerner SP, Schoenberg MP.
    J Urol; 2006 Jun 15; 175(6):2048-53; discussion 2053. PubMed ID: 16697800
    [Abstract] [Full Text] [Related]

  • 14. Lymphovascular invasion and the presence of more than three tumors are associated with poor outcomes of muscle-invasive bladder cancer after bladder-conserving therapies.
    Zhang M, Tao R, Zhang C, Shen Z.
    Urology; 2010 Oct 15; 76(4):902-7. PubMed ID: 20709377
    [Abstract] [Full Text] [Related]

  • 15. Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients.
    Tilki D, Reich O, Svatek RS, Karakiewicz PI, Kassouf W, Novara G, Ficarra V, Chade DC, Fritsche HM, Gerwens N, Izawa JI, Lerner SP, Schoenberg M, Stief CG, Skinner E, Lotan Y, Sagalowsky AI, Shariat SF.
    J Urol; 2010 May 15; 183(5):1757-63. PubMed ID: 20299059
    [Abstract] [Full Text] [Related]

  • 16. Presentation, location and overall survival of pelvic recurrence after radical cystectomy for transitional cell carcinoma of the bladder.
    Dhar NB, Jones JS, Reuther AM, Dreicer R, Campbell SC, Sanii K, Klein EA.
    BJU Int; 2008 Apr 15; 101(8):969-72. PubMed ID: 18005201
    [Abstract] [Full Text] [Related]

  • 17. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
    Saito K, Kawakami S, Fujii Y, Sakura M, Masuda H, Kihara K.
    J Urol; 2007 Dec 15; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
    [Abstract] [Full Text] [Related]

  • 18. Predicting individual outcomes after radical cystectomy: an external validation of current nomograms.
    Zaak D, Burger M, Otto W, Bastian PJ, Denzinger S, Stief CG, Buchner H, Hartmann A, Wieland WF, Shariat SF, Fritsche HM.
    BJU Int; 2010 Aug 15; 106(3):342-8. PubMed ID: 20002664
    [Abstract] [Full Text] [Related]

  • 19. Prognostic value of lymphovascular invasion in bladder cancer in patients treated with radical cystectomy.
    Palmieri F, Brunocilla E, Bertaccini A, Guidi M, Pernetti R, Morselli-Labate AM, Martorana G.
    Anticancer Res; 2010 Jul 15; 30(7):2973-6. PubMed ID: 20683041
    [Abstract] [Full Text] [Related]

  • 20. Neurofuzzy modeling to determine recurrence risk following radical cystectomy for nonmetastatic urothelial carcinoma of the bladder.
    Catto JW, Abbod MF, Linkens DA, Larré S, Rosario DJ, Hamdy FC.
    Clin Cancer Res; 2009 May 01; 15(9):3150-5. PubMed ID: 19336522
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.